AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Hansa Biopharma AB (publ)

SEK 39.34 +$6.64 (+20.31%)
STO · 30 Oct 2026 11:59 UTC
Previous Close
SEK 39.34
Day Range
SEK 39.04SEK 40.00
Year Range
SEK 23.52SEK 48.22
Market Cap
3.92B
AVG Volume
595.63K
Trailing/Forward PE
-5.01/-
PEG ratio
0.05
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
Stockholm Stock ExchangeSE
Revenue (SEK) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HNSA.ST Revenue (SEK) by quarter, trailing twelve months
PeriodRevenue (SEK)
26 Q2189.46M
26 Q1190.49M
25 Q4222.26M
25 Q3178.61M
25 Q2196.47M
25 Q1181.68M
24 Q4171.32M
24 Q3189.39M
24 Q2163.56M
24 Q1165.88M
Net Income (SEK) · TTM
-1B-750M-500M-250M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HNSA.ST Net Income (SEK) by quarter, trailing twelve months
PeriodNet Income (SEK)
26 Q2-770.15M
26 Q1-688.5M
25 Q4-529.25M
25 Q3-640.63M
25 Q2-596.17M
25 Q1-625.24M
24 Q4-806.74M
24 Q3-654.78M
24 Q2-801.64M
24 Q1-844.88M
Operating Income (SEK) · TTM
-800M-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HNSA.ST Operating Income (SEK) by quarter, trailing twelve months
PeriodOperating Income (SEK)
26 Q2-589.01M
26 Q1-569.68M
25 Q4-520.99M
25 Q3-539.72M
25 Q2-508.72M
25 Q1-535.66M
24 Q4-595.14M
24 Q3-633.46M
24 Q2-718.68M
24 Q1-765.46M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (SEK) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: HNSA.ST

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 11 Nov 2026.

Hansa Biopharma AB (publ)
HNSA.ST
Stockpicker

Video analysis: HNSA.ST

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: HNSA.ST

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.